Gynoveda (gynoveda.com) — Website Traffic Estimation
Report generated: 25 August 2026. Prepared per the website-traffic-estimation workflow, cross-referencing user-provided SimilarWeb panel data (highest priority) against server-side StatShow estimates. Business context drawn from the accompanying business-analysis.md.
1. Sources Consulted
| Source | Status | Data Returned | Role in Report |
|---|---|---|---|
| SimilarWeb (user-provided, typed data) | Blocked from server (CloudFront 403) — data supplied by user | Country Rank, Category Rank, Bounce Rate, Pages/Visit, Avg Duration, Total Monthly Visits, Geo split | Highest priority — authoritative for all overlapping metrics |
| StatShow (statshow.com/www/gynoveda.com) | ✅ Working | Global Rank, monthly/daily visitors & pageviews, worth, ad-revenue estimate | Cross-reference / sanity check |
| WorthOfWeb (worthofweb.com) | ❌ Blocked (Cloudflare "Just a moment…" challenge) | None | Not used |
| Semrush / SpyFu / HypeStat / CuteStat / Alexa | ❌ Blocked / dead (per standard workflow) | None | Not used |
Priority rule applied: SimilarWeb figures supplied by the user take precedence over all server-side estimates. StatShow is treated as a corroborating cross-reference only.
2. Raw Numbers
2a. SimilarWeb — user-provided (June/July 2026 panel)
Source: SimilarWeb, supplied by user (typed capture). Highest-priority data.
| Metric | Value |
|---|---|
| Total Monthly Visits | 136,400 |
| Country Rank | 22,102 |
| Category | Data not available |
| Category Rank | 13 |
| Bounce Rate | 24.21% |
| Pages per Visit | 2.42 |
| Avg Visit Duration | 00:00:54 |
| Traffic by Country | India 59.94% · US 18.67% · UK 8.99% · Pakistan 6.85% · Canada 5.55% |
Note: the five listed countries sum to exactly 100.00%, so this is the complete geographic breakdown (no residual "other" bucket).
2b. StatShow — server-side estimate
Source: https://www.statshow.com/www/gynoveda.com (captured 25 Aug 2026)
| Metric | Value |
|---|---|
| Global Rank | #89,563 |
| Monthly Visitors (est.) | ~159,870 |
| Monthly Pageviews (est.) | ~351,720 |
| Daily Visitors (est.) | 5,329 |
| Daily Pageviews (est.) | 11,724 |
| Estimated Worth | $12,410 |
| Est. Monthly Ad Revenue | $1,020 (ad-only model — not meaningful for an e-commerce store, see Caveats) |
| Server IP | 23.227.3.x (Shopify CDN range) |
| Rank trend | +35% (improved) over last 3 months |
3. Aggregated Summary
3a. Visitor / engagement reconciliation
| Metric | SimilarWeb (user) | StatShow (est.) | Agreement |
|---|---|---|---|
| Monthly visits | 136,400 | ~159,870 | ±17% — close |
| Implied monthly pageviews (visits × pages/visit) | ~330,100 (×2.42) | ~351,720 | ±6% — very close |
| Pages per visit | 2.42 | ~2.20 (11,724/5,329) | Consistent |
| Rank | Country #22,102 | Global #89,563 | Different rank types; both indicate a top-100k–ish property |
Read: The two independent sources converge on ~140K–160K monthly visits and ~2.2–2.4 pages/visit. This is a medium-traffic, content/community-driven property — not a thin micro-site. The ~17% gap is well within normal panel-vs-estimator variance and does not require reconciliation.
3b. Derived metrics (from SimilarWeb, primary)
| Derived metric | Calculation | Value |
|---|---|---|
| Monthly pageviews | 136,400 × 2.42 | ~330,100 |
| Daily visits | 136,400 ÷ 30 | ~4,547 |
| Daily pageviews | ~330,100 ÷ 30 | ~11,003 |
| India visits/month | 136,400 × 59.94% | ~81,746 |
| US visits/month | 136,400 × 18.67% | ~25,463 |
| UK visits/month | 136,400 × 8.99% | ~12,266 |
| Pakistan visits/month | 136,400 × 6.85% | ~9,346 |
| Canada visits/month | 136,400 × 5.55% | ~7,570 |
4. Key Insights
- Traffic tier: Medium (100K–1M monthly visits). At ~136K visits/month, Gynoveda sits comfortably in the "regional brand / popular blog" tier — a credible category leader in Ayurvedic women's health, consistent with its funded-D2C status and ~1,400 live Meta ads.
- Exceptionally low bounce rate (24.21%). For an e-commerce/content site this is unusually strong engagement — most consumer sites sit 40–60%. It signals a content/community-led audience (the 882-URL SEO hub + 1.5L-member "Circle of Sisterhood" FB group) where users read multiple pages per session rather than bounce off a landing page.
- Short session, multi-page behavior. Avg visit 54s but 2.42 pages/visit means users skim 2–3 pages quickly — typical of intent-driven health-content seekers (PCOS/fertility symptom research) hopping between articles and product pages.
- Geographic split is counter-intuitive for an "India-only" brand. Business context states Gynoveda ships India-only (no confirmed international fulfillment), yet ~40% of traffic is non-India: US 18.67%, UK 8.99%, Pakistan 6.85%, Canada 5.55%. This strongly implies:
- A large desi diaspora audience reached via Hindi/English Meta video ads and YouTube (78K subs);
- High-intent overseas women researching Ayurvedic fertility/PCOS alternatives.
- CRO implication: there is demonstrable unmet international demand. The catalog gaps in business-analysis.md (no international shipping, no diaspora localization) are validated by this traffic signal — a clear expansion opportunity.
- Rank is improving. StatShow notes a +35% rank improvement over 3 months; combined with the sustained ~1,400-ad Meta footprint (since May 2026), traffic is likely on an upward trajectory, not declining.
- Mobile-dominant audience (context bridge). While geo is from SimilarWeb, the CrUX data in business-analysis.md shows 93.2% phone / 6.78% desktop. The traffic is overwhelmingly smartphone, India-centric-device, and international-in-origin — a useful tension: the devices are Indian-mobile, but ~40% of sessions originate abroad. Mobile-first optimization is non-negotiable.
5. Caveats
- SimilarWeb data is user-provided and undated at the source level. Reported here as captured (月度 visits 136,400). Treat as a recent panel snapshot; re-verify if decisions depend on freshness beyond ~1 month.
- Category is "data not available" / Category Rank 13 is unlabeled. Without the category name, "Rank 13" cannot be interpreted (e.g., rank 13 in "Health > Reproductive Health" vs. a broad "Beauty" bucket mean very different things). Flagged, not guessed.
- StatShow ad-revenue (~$1,020/mo) and worth ($12,410) are not meaningful for Gynoveda. These tools assume ad-monetized sites. Gynoveda is an e-commerce/D2C Ayurveda brand — its real revenue is product sales (founder-stated ~$12M annual run-rate in business-analysis.md), dwarfing any ad estimate. Ignore the dollar figures; use only StatShow's visitor/pageview/rank figures.
- StatShow vs. SimilarWeb on Shopify undercounting. The standard workflow warns StatShow often undercounts Shopify-hosted sites by 100–1,000×. Here StatShow (159,870) is actually higher than SimilarWeb (136,400), so the undercount caveat does not apply — the two agree. (StatShow resolved gynoveda.com's IP to Shopify's 23.227.3.x range, likely via the shop.gynoveda.com storefront; the main site itself is Next.js+Envoy.)
- All third-party traffic numbers are estimates, not GA ground truth. They are panel/algorithmic approximations. For precise, first-party interpretation, integrating the client's GA4 would replace these ranges with exact figures — recommended as a follow-up.
- Blocked sources. SimilarWeb (server IP blocklisted at CloudFront), WorthOfWeb (Cloudflare challenge), Semrush/SpyFu/HypeStat/CuteStat/Alexa (registration/dead/challenge) returned nothing. No data was fabricated to fill gaps.
6. Bottom Line
Gynoveda draws an estimated ~136K monthly visits (SimilarWeb) / ~160K (StatShow) — a healthy Medium-tier property with strong engagement (24% bounce, 2.4 pages/session) and a notably international audience (~40% outside India) despite an India-only fulfillment model. Traffic is mobile-dominant and trending up. The international demand signal is the single most actionable CRO/business insight: it directly supports the expansion gaps (international shipping, diaspora localization) flagged in the companion business-analysis.md.
Citations
- SimilarWeb (user-provided typed data, June/July 2026 panel) — Country Rank 22,102; Category Rank 13; Bounce 24.21%; Pages/Visit 2.42; Avg Duration 0:54; Monthly Visits 136,400; Geo: IN 59.94% / US 18.67% / UK 8.99% / PK 6.85% / CA 5.55%.
- https://www.statshow.com/www/gynoveda.com — Global Rank #89,563; ~159,870 monthly visitors; ~351,720 monthly pageviews; worth $12,410; ad-revenue $1,020 (not meaningful for e-commerce); IP 23.227.3.x; +35% rank in 3 months.
- https://cruxvis.withgoogle.com/ (origin gynoveda.com) — CrUX form factors: 93.2% phone / 6.78% desktop / 0% tablet (2026-08-22) — cited from business-analysis.md for device-context bridge.
- business-analysis.md (accompanying report) — funding ($11M raised, ~$12M run-rate), 1.5L-member community, 882-URL SEO hub, ~1,400 Meta ads, India-only fulfillment statement, catalog/expansion gaps.